Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma.
about
Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Reactivating TP53 signaling by ...... n for high-risk neuroblastoma.
@en
Reactivating TP53 signaling by ...... n for high-risk neuroblastoma.
@nl
type
label
Reactivating TP53 signaling by ...... n for high-risk neuroblastoma.
@en
Reactivating TP53 signaling by ...... n for high-risk neuroblastoma.
@nl
prefLabel
Reactivating TP53 signaling by ...... n for high-risk neuroblastoma.
@en
Reactivating TP53 signaling by ...... n for high-risk neuroblastoma.
@nl
P2093
P2860
P356
P1433
P1476
Reactivating TP53 signaling by ...... n for high-risk neuroblastoma.
@en
P2093
Angelika Eggert
Annette Künkele
Annika Winkler
Hedwig E Deubzer
Jasmin Wünschel
Johannes H Schulte
Jutta Proba
Karin Schmelz
Patrick Hundsdoerfer
Viktor Arnhold
P2860
P304
P356
10.18632/ONCOTARGET.23409
P407
P577
2017-12-18T00:00:00Z